Filing Details

Accession Number:
0001144204-15-016825
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-17 18:43:01
Reporting Period:
2015-03-13
Filing Date:
2015-03-17
Accepted Time:
2015-03-17 18:43:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1598646 Minerva Neurosciences Inc. NERV Pharmaceutical Preparations (2834) 260784194
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
200406 Johnson & Johnson One Johnson &Amp; Johnson Plaza
New Brunswick NJ 08933
No No Yes No
924020 Johnson & Johnson Innovation - Jjdc, Inc. 410 George Street
New Brunswick NJ 08901
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-13 607,903 $4.81 4,500,159 No 4 P Indirect By Johnson & Johnson Innovation - JJDC, Inc.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Johnson & Johnson Innovation - JJDC, Inc.
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants (right to buy) Acquisiton 2015-03-13 607,903 $0.13 607,903 $5.77
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
607,903 2015-03-18 2017-03-18 No 4 P Indirect
Footnotes
  1. The transaction is subject to customary closing conditions and is expected to close on or about 03/18/2015.
  2. Consists of 3,892,256 shares of Common Stock and 607,903 shares of Common Stock underlying immediately exercisable warrants.
  3. The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person (formerly known as Johnson & Johnson Development Corporation).